- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund
+ Add to WatchlistTEPF:GR
13.8600 EUR 0.5100 3.55%As of 06:00:56 ET on 05/23/2013.
Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TEPF)
| Open: | 14.2100 | High - Low: | 14.2100 - 13.8600 | Primary Exchange: | Stuttgart |
|---|---|---|---|---|---|
| Volume: | 6,260 | 52-Week Range: | 9.9400 - 14.8800 | Beta vs NBI: | 0.8225 |
Fund Profile & Information for TEPF
Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).
| Inception Date: | 2000-04-03 | Telephone: | 352-46-66-67-1 |
|---|---|---|---|
| Managers: | EVAN MCCULLOCH | ||
| Web Site: | www.franklintempleton.lu | ||
Fundamentals for TEPF
| NAV | - |
|---|---|
| Assets (M) | (on 2013-03-29) 541.1390 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | - |
| Average 52-Week % Premium | - |
| Fund Leveraged | N |
Dividends for TEPF
No dividends reported
Performance for TEPF
| 1-Month | +4.97% | 1-Year | +40.47% |
|---|---|---|---|
| 3-Month | +22.40% | 3-Year | +28.24% |
| Year To Date | +35.31% | 5-Year | +23.35% |
| Expense Ratio | 1.85 |
Top Fund Holdings for TEPF
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 1,047,800 | 41,335,710 | 10.111% |
| Celgene Corp | 371,200 | 36,733,952 | 8.986% |
| Biogen Idec Inc | 166,440 | 25,977,955 | 6.355% |
| Amgen Inc | 279,800 | 23,911,708 | 5.849% |
| Alexion Pharmaceuticals Inc | 193,400 | 18,177,666 | 4.447% |
| Vertex Pharmaceuticals Inc | 308,000 | 13,792,240 | 3.374% |
| Medivation Inc | 214,100 | 11,638,476 | 2.847% |
| Pharmacyclics Inc | 143,800 | 9,969,654 | 2.439% |
| Ariad Pharmaceuticals Inc | 491,300 | 9,767,044 | 2.389% |
| Regeneron Pharmaceuticals Inc | 52,600 | 9,149,244 | 2.238% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page